Article Details
Retrieved on: 2018-10-25 04:30:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>New Enterprise Associates</b> 16 reported SC 13D form with the SEC for Marker Therapeutics, Inc. Access it here: 000107261318000512. As reported by ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here